This site does not have SSL enabled. Please visit http://ir.mabvax.com/news/detail/125/mabvax-therapeutics-receives-u-s-patent-for-fully-human-antibodies-targeting-the-antigen-gd2-expressed-on-sarcoma-melanoma-and-neuroblastoma.